Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.910
-0.010 (-0.52%)
At close: Apr 28, 2026, 4:00 PM EDT
1.910
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 4.77, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 149.74% from the current stock price of 1.91.
Analyst Consensus: Hold
* Price targets were last updated on Mar 2, 2026.
Analyst Ratings
The average analyst rating for Treace Medical Concepts stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $7.5 → $7 | Strong Buy | Maintains | $7.5 → $7 | +266.49% | Mar 2, 2026 |
| Stifel | Stifel | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +57.07% | Jan 7, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +57.07% | Dec 18, 2025 |
| Truist Securities | Truist Securities | Hold Reiterates $7 → $4 | Hold | Reiterates | $7 → $4 | +109.42% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $6.5 → $5.85 | Hold | Maintains | $6.5 → $5.85 | +206.28% | Nov 7, 2025 |
Financial Forecast
Revenue This Year
210.04M
from 212.69M
Decreased by -1.25%
Revenue Next Year
227.22M
from 210.04M
Increased by 8.18%
EPS This Year
-0.93
from -0.93
EPS Next Year
-0.86
from -0.93
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 217.3M | 254.5M | |
| Avg | 210.0M | 227.2M | |
| Low | 200.9M | 209.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.1% | 21.2% | |
| Avg | -1.2% | 8.2% | |
| Low | -5.5% | -0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.95 | -0.65 | |
| Avg | -0.93 | -0.86 | |
| Low | -0.91 | -0.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.